Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis is a clinical trial[1].
Key Facts
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis is in the country of United States[2].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's instance of is recorded as clinical trial[3].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's start time is recorded as +2019-03-01T00:00:00Z[4].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's end time is recorded as +2021-03-01T00:00:00Z[5].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's sponsor is recorded as Oregon Health and Science University[6].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's main subject is recorded as sarcoidosis[7].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's number of participants is recorded as {'unit': '1', 'amount': '+5'}[8].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's title is recorded as Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis[9].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's ClinicalTrials.gov ID is recorded as NCT03793439[11].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+89'}[12].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's research intervention is recorded as tofacitinib[13].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's clinical trial phase is recorded as phase I clinical trial[14].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's research site is recorded as Oregon Health and Science University[15].
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis's study type is recorded as interventional study[16].